Ethical implications of developing RNA-based therapies for cardiovascular disorders

Area of Science:

• Biomedical Ethics
• Cardiovascular Medicine
• RNA Therapeutics

Background:

• The success of RNA-based vaccines has increased interest in RNA therapeutics for various diseases.
• There's a growing number of RNA-based therapies being investigated for cardiovascular disorders.
• Ethical considerations for RNA-based therapies, particularly in cardiovascular medicine, remain underexplored.

Purpose of the Study:

• To evaluate the ethical framework surrounding RNA-based therapies for cardiovascular disorders.
• To analyze key ethical topics including risk-benefit assessment and justice in research and clinical application.

Main Methods:

• Focus on risk-benefit analysis, encompassing public awareness management.
• Examination of justice principles in both the research and clinical settings of RNA-based cardiovascular therapies.

Main Results:

• Identified gaps in ethical assessments specific to RNA-based cardiovascular therapies.
• Highlighted the need for structured ethical analysis concerning risk communication and equitable access.

Conclusions:

• Ethical frameworks are crucial for the responsible development and implementation of RNA-based cardiovascular therapies.
• Further research is needed to address the unique ethical challenges, ensuring patient safety and societal benefit.